Skip to main content
Fig. 1 | BMC Medical Imaging

Fig. 1

From: A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures

Fig. 1

Flowchart of Diffusion/Perfusion Project (DPP) Suite. The DPP Suite is used for diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) measurements in focal and diffuse abnormalities in multiple sclerosis (MS) patients. OspFE = Ferrara Hospital; MRI = magnetic resonance imaging; FLAIR = axial fluid-attenuated inversion recovery MRI images; T1 = 2D axial non-enhanced T1-weighted spin-Echo or 3D non-enhanced T1-weighted gradient-Echo MRI images; Gd T1 = Gadolinium-enhanced T1-weighted spin-Echo MRI images; r_T1 = registered 2D axial non-enhanced T1-weighted spin-Echo or 3D non-enhanced T1-weighted gradient-Echo MRI images; r_Gd T1 = registered Gadolinium-enhanced T1-weighted spin-Echo MRI images; ROI = regions of interest; NAWM = normal appearing white matter; NAGM = normal appearing grey matter; ADC = apparent diffusion coefficient; CBF = cerebral blood flow; CBV = cerebral blood volume; MTT = mean transit time

Back to article page